Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Design
2.2. Setting, Participants and Data Collection
2.3. Selection Criteria for CM Patients and FDRs
2.4. Randomization, Intervention and Control Procedures
2.5. Outcomes
2.6. Statistical Analysis
2.7. Ethics
3. Results
3.1. Study Population
3.2. Information Transmission as Reported by Index Cases
3.3. Information Transmission as Reported by FDRs
3.4. Primary Outcome
3.5. Secondary Outcomes
4. Discussion
4.1. Primary and Secondary Outcomes
4.2. Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020, GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
- Dyba, T.; Randi, G.; Bray, F.; Martos, C.; Giusti, F.; Nicholson, N.; Gavin, A.; Flego, M.; Neamtiu, L.; Dimitrova, N.; et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur. J. Cancer 2021, 157, 308–347. [Google Scholar] [CrossRef]
- Swetter, S.M.; Pollitt, R.A.; Johnson, T.M.; Brooks, D.R.; Geller, A.C. Behavioral determinants of successful early melanoma detection. Cancer 2012, 118, 3725–3734. [Google Scholar] [CrossRef] [Green Version]
- Kovalyshyn, I.; Dusza, S.W.; Siamas, K.; Halpern, A.C.; Argenziano, G.; Marghoob, A.A. The impact of physician screening on melanoma setection. Arch. Dermatol. 2011, 147, 1269–1275. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dessinioti, C.; Geller, A.C.; Stergiopoulou, A.; Swetter, S.M.; Baltas, E.; Mayer, J.E.; Johnson, T.M.; Talaganis, J.; Trakatelli, M.; Tsoutsos, D.; et al. Association of skin examination behaviors and thinner nodular vs superficial spreading melanoma at diagnosis. JAMA Dermatol. 2018, 154, 544–553. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wernli, K.J.; Henrikson, N.B.; Morrison, C.C.; Nguyen, M.; Pocobelli, G.; Blasi, P.R. Screening for skin cancer in adults: Updated evidence report and systematic review for the US preventive services task force. JAMA 2016, 316, 436–447. [Google Scholar] [CrossRef] [PubMed]
- Johansson, M.; Brodersen, J.; Gøtzsche, P.C.; Jørgensen, K.J. Screening for reducing morbidity and mortality in malignant melanoma. Cochrane Database Syst. Rev. 2019, 6, CD012352. [Google Scholar] [CrossRef]
- Buja, A.; Sartor, G.; Scioni, M.; Vecchiato, A.; Bolzan, M.; Rebba, V.; Sileni, V.C.; Palozzo, A.C.; Montesco, M.; Del Fiore, P.; et al. Estimation of direct melanoma-related costs by disease stage and by phase of diagnosis and treatment according to clinical guidelines. Acta Derm. Venerol. 2018, 98, 218–224. [Google Scholar] [CrossRef] [Green Version]
- Olsen, C.M.; Carroll, H.J.; Whiteman, D.C. Familial melanoma: A meta-analysis and estimates of attributable fraction. Cancer Epidemiol. Biomark. Prev. 2010, 19, 65–73. [Google Scholar] [CrossRef] [Green Version]
- Ford, D.; Bliss, J.M.; Swerdlow, A.J.; Armstrong, B.K.; Franceschi, S.; Green, A.; Holly, E.A.; Mack, T.; MacKie, R.M.; Osterlind, A. Risk of cutaneous melanoma associated with a family history of the disease.The Interventional Melanoma Analysis Group (IMAGE). Int. J. Cancer 1995, 62, 377–381. [Google Scholar] [CrossRef] [Green Version]
- Rhodes, A.R.; Weinstock, M.A.; Fitzpatrick, T.B.; Mihm, M.C., Jr.; Sober, A.J. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987, 258, 3146–3154. [Google Scholar] [CrossRef]
- ALD n° 30. Guide Médecin sur le Mélanome Cutané. Available online: https://www.has-sante.fr/upload/docs/application/pdf/201203/ald_30_guide_melanome_web.pdf (accessed on 20 April 2022).
- Losina, E.; Walensky, R.P.; Geller, A.; Beddingfield, F.C., 3rd; Wolf, L.L.; Gilchrest, B.A.; Freedberg, K.A. Visual screening for malignant melanoma, a cost-effectiveness analysis. Arch. Dermatol. 2007, 143, 21–28. [Google Scholar] [CrossRef]
- Coroiu, A.; Moran, C.; Bergeron, C.; Thombs, B.D.; Geller, A.C.; Kingsland, E.; Körner, A. Operationalization of skin self-examination in randomized controlled trials with individuals at increased risk for melanoma: A systematic review. Patient Educ. Couns. 2020, 103, 1013–1026. [Google Scholar] [CrossRef]
- Bowen, D.J.; Hay, J.L.; Mayer, J.; Kuniyuki, A.; Meischke, H.; Harris, J.; Asgari, M.; Shoveller, J.; Press, N.; Burke, W. Predictors of recruited melanoma families into a behavioral intervention project. Contemp. Clin. Trials 2012, 33, 85–92. [Google Scholar] [CrossRef] [Green Version]
- Bowen, D.J.; Albrecht, T.; Hay, J.; Eggly, S.; Harris-Wei, J.; Meischke, H.; Burke, W. Communication among melanoma family members. J. Health Commun. 2017, 22, 198–204. [Google Scholar] [CrossRef] [Green Version]
- Hay, J.; Shuk, E.; Brady, M.S.; Berwick, M.; Ostroff, J.; Halpern, A. Family communication after melanoma diagnosis. Arch. Dermatol. 2008, 144, 553–554. [Google Scholar] [CrossRef]
- Oliveria, S.A.; Heneghan, M.K.; Halpern, A.C.; Hay, J.L.; Geller, A.C. Communication about family members’ risk of melanoma: Self-reported practices of dermatologists in the United States. Arch. Dermatol. 2012, 148, 621–627. [Google Scholar] [CrossRef] [Green Version]
- Berton, M.; Perrinaud, A.; Samimi, M.; Delaplace, M.; Vaillant, L.; Machet, L. Utilité d’une fiche de conseils pour la photoprotection et le dépistage des patients et de leur famille après un diagnostic de mélanome. Ann. Dermatol. Venereol. 2013, 140, S407–S408. [Google Scholar] [CrossRef]
- Caille, A.; Kerry, S.; Tavernier, E.; Leyrat, C.; Eldridge, S.; Giraudeau, B. Timeline cluster: A graphical tool to identify risk of bias in cluster randomised trials. BMJ 2016, 354, i4291. [Google Scholar] [CrossRef] [Green Version]
- Zeger, S.L.; Liang, K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42, 124–130. [Google Scholar] [CrossRef] [Green Version]
- Eldridge, S.; Kerry, S.M. A Practical Guide to Cluster Randomised Trials in Health Services Research; John Wiley & Sons: Chichester, UK, 2011. [Google Scholar]
- Ridout, M.S.; Demetrio, C.G.B.; Firth, D. Estimating Intraclass Correlation for Binary Data. Biometrics 1999, 55, 137–148. [Google Scholar] [CrossRef]
- Manne, S.; Fasanella, N.; Connors, J.; Floyd, B.; Wang, H.; Lessin, S. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: Prevalence and predictors. Prev. Med. 2004, 39, 36–47. [Google Scholar] [CrossRef]
- Sarikaya Solak, S.; Yondem, H.; Cicin, I. Evaluating sun protection behaviors and skin self-examination practices among the family members of melanoma patients in Turkey: A cross-sectional survey study. Dermatol. Ther. 2020, 33, e14268. [Google Scholar] [CrossRef]
- Geller, A.C.; Emmons, K.M.; Brooks, D.R.; Powers, C.; Zhang, Z.; Koh, H.K.; Heeren, T.; Sober, A.J.; Li, F.; Gilchrest, B.A. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 2006, 107, 806–814. [Google Scholar] [CrossRef]
- Manne, S.; Jacobsen, P.B.; Ming, M.E.; Winkel, G.; Dessureault, S.; Lessin, S.R. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol. 2010, 29, 583–593. [Google Scholar] [CrossRef] [Green Version]
- Bowen, D.J.; Hay, J.; Meischke, H.; Mayer, J.A.; Harris-Wai, J.; Burke, W. Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives. Cancer Causes Control 2019, 30, 225–233. [Google Scholar] [CrossRef]
- Rodríguez, V.M.; Berwick, M.; Hay, J.L. Communication about melanoma and risk reduction after melanoma diagnosis. Psycho-Oncology 2017, 26, 2142–2148. [Google Scholar] [CrossRef]
- Oliveria, S.A.; Shuk, E.; Hay, J.L.; Heneghan, M.; Goulart, J.M.; Panageas, K.; Geller, A.C.; Halpern, A.C. Melanoma survivors, health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology 2013, 22, 106–116. [Google Scholar] [CrossRef] [Green Version]
- Loescher, L.J.; Crist, J.D.; Siaki, L.A. Perceived intrafamily melanoma risk communication. Cancer Nurs. 2009, 32, 203–210. [Google Scholar] [CrossRef] [Green Version]
- McWhirter, J.E.; Hoffman-Goetz, L. Visual images for patient skin self-examination and melanoma detection: A systematic review of published studies. J. Am. Acad. Dermatol. 2013, 69, 47–55. [Google Scholar] [CrossRef]
- Loescher, L.J.; Crist, J.D.; Cranmer, L.; Curiel-Lewandrowski, C.; Warneke, J.A. Melanoma high-risk families’ perceived health care provider risk communication. J. Cancer Educ. 2009, 24, 301–307. [Google Scholar] [CrossRef] [PubMed]
Intervention Group Written and Oral Information n = 166 | Control Group Oral Information Alone n = 114 | |
---|---|---|
FDR characteristics | ||
Age, ni = 165, nc = 114 | 52 (17) | 50 (18) |
Men, ni = 166, nc = 114 | 75 (45.2) | 45 (39.5) |
Level of education, ni = 166, nc = 114 | ||
Secondary school | 24 (14.5) | 15 (13.2) |
Certificate of professional competence/Professional study certificate | 34 (20.5) | 26 (22.8) |
High school diploma | 43 (25.9) | 38 (33.3) |
Bachelor’s degree | 32 (19.3) | 16 (14.0) |
Master’s degree | 32 (19.3) | 18 (15.8) |
Other | 1 (0.6) | 1 (0.9) |
Occupational status, ni = 166, nc = 114 | ||
Full-time professional | 95 (57.2) | 59 (51.8) |
Part-time professional | 10 (6.0) | 7 (6.1) |
No activity | 1 (0.6) | 0 (0.0) |
Work time accident/occupational disease | 2 (1.2) | 0 (0.0) |
Student | 6 (3.6) | 7 (6.1) |
Disability | 1 (0.6) | 0 (0.0) |
Unemployment | 0 (0.0) | 3 (2.6) |
Retired | 49 (29.5) | 36 (31.6) |
Other | 2 (1.2) | 2 (1.8) |
Business, ni = 165, nc = 113 | ||
Farmer | 2 (1.2) | 0 (0.0) |
Artisan, trader, head of enterprise | 10 (6.1) | 6 (5.3) |
Executive, higher intellectual profession | 25 (15.2) | 17 (15.0) |
Intermediate occupation | 11 (6.7) | 2 (1.8) |
Employed | 58 (35.2) | 38 (33.6) |
Worker | 1 (0.6) | 3 (2.7) |
Other | 58 (35.2) | 47 (41.6) |
Relationship status to index case, ni = 165, nc = 114 | ||
Father or mother | 20 (12.1) | 17 (14.9) |
Brother or sister | 69 (41.8) | 41 (36.0) |
Son or daughter | 76 (46.1) | 56 (49.1) |
Family situation, ni = 165, nc = 114 | ||
Married | 113 (68.5) | 76 (66.7) |
Single | 36 (21.8) | 19 (16.7) |
Widow (er) | 6 (3.6) | 5 (4.4) |
Separated/divorced | 10 (6.1) | 14 (12.3) |
FDRs with children, ni =165, nc = 114 | 117 (70.9) | 80 (70.2) |
Number of children, ni = 117, nc = 80 | 2 (2; 3) | 2 (2; 3) |
History of melanoma, ni = 161, nc = 112 | 6 (3.7) | 3 (2.6) |
History of another cancer, ni = 163, nc = 113 | 12 (7.4) | 10 (8.8) |
Skin cancer *, ni = 12, nc = 10 | 5 (41.7) | 6 (60.0) |
Other type of cancer *, ni = 12, nc = 10 | 7 (58.3) | 5 (50.0) |
Intervention Group Written and Oral Information n = 166 | Control Group Oral Information n = 114 | OR [95% CI] | p-Value | |
---|---|---|---|---|
Primary outcome: TCE performed strictly within the period of the study * | 60 (36.1%) | 45 (39.5%) | 0.9 [0.5 to 1.5] | 0.63 |
Sensitivity analysis of the primary outcome: all TCEs performed, including TCE performed just before the inclusion period or with a missing date of appointment | 71 (42.8%) | 56 (49.1%) | 0.8 [0.5 to 1.3] | 0.39 |
Secondary outcomes | ||||
TCE planned with a scheduled appointment but not yet completed | 8 (4.8%) | 1 (0.9%) | 5.5 [0.7 to 45.3] | 0.11 |
TCE planned with no scheduled appointment yet | 36 (21.7%) | 24 (21.1%) | 1.1 [0.6 to 1.9] | 0.88 |
Intervention Group Written and Oral Information n = 166 | Control Group Oral Information n = 114 | OR [95% CI] | p-Value | |
---|---|---|---|---|
Use of sun protection | 121 (72.9%) | 88 (77.2%) | 0.8 [0.5 to 1.4] | 0.48 |
Avoidance of sun exposure | 39 (23.5%) | 22 (19.3%) | 1.4 [0.7 to 2.7] | 0.40 |
Wearing protective clothes | 70 (57.9%) | 38 (43.2%) | 1.5 [0.9 to 3.3] | 0.13 |
Use of high index sunscreen | 105 (63.3%) | 70 (61.4%) | 1.1 [0.6 to 1.9] | 0.73 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marcé, D.; Le Vilain-Abraham, F.; Bridou, M.; Quéreux, G.; Dupuy, A.; Lesimple, T.; Le Corre, Y.; Wierzbicka-Hainaut, E.; Legoupil, D.; Célérier, P.; et al. Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial. Cancers 2022, 14, 3864. https://doi.org/10.3390/cancers14163864
Marcé D, Le Vilain-Abraham F, Bridou M, Quéreux G, Dupuy A, Lesimple T, Le Corre Y, Wierzbicka-Hainaut E, Legoupil D, Célérier P, et al. Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial. Cancers. 2022; 14(16):3864. https://doi.org/10.3390/cancers14163864
Chicago/Turabian StyleMarcé, Diane, Floriane Le Vilain-Abraham, Morgiane Bridou, Gaelle Quéreux, Alain Dupuy, Thierry Lesimple, Yannick Le Corre, Ewa Wierzbicka-Hainaut, Delphine Legoupil, Philippe Célérier, and et al. 2022. "Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial" Cancers 14, no. 16: 3864. https://doi.org/10.3390/cancers14163864
APA StyleMarcé, D., Le Vilain-Abraham, F., Bridou, M., Quéreux, G., Dupuy, A., Lesimple, T., Le Corre, Y., Wierzbicka-Hainaut, E., Legoupil, D., Célérier, P., Maillard, H., Machet, L., & Caille, A. (2022). Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial. Cancers, 14(16), 3864. https://doi.org/10.3390/cancers14163864